abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to compound of structural formula n , n which can be applied for treatment, prevention or carrying out treatment of neurological disorder. In formula (Iva) m is equal 0; n is equal 1; R 1 and R 2 are, each independently, hydrogen, C 1 -C 4 alkyl or C 3 -C 6 cycloalkyl; R 3 and R 4 are, each independently, hydrogen or C 1 -C 4 alkyl; R 5 is hydrogen and R 6 and R 7 are, each independently hydrogen, halogen, C 1 -C 4 alkyl, C 6 -C 10 aryl, 5-10-membered heteroaryl, which contains one O atom, one S atom and/or 1-4 N atom(s), 3-8-membered heterocyclyl, containing 1-2 heteroatoms, selected from O, S and N, C 1 -C 4 alcoxyl or aminoC 1 -C 4 alkyl. n EFFECT: invention relates to pharmaceutical industry, which contains claimed compound, and to method of treatment, prevention or carrying out of treatment of neurological disorder such as psychosis or schizophrenia. n 54 cl, 2 tbl |